Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million
markets.businessinsider.com · 2021-05-10
Saint-Herblain (France), May 10, 2021 – Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic...
Read the full story at markets.businessinsider.com →
Is VALN undervalued? See TickrTrends' fair value analysis →